295 related articles for article (PubMed ID: 31654895)
1. Protective properties of milk sphingomyelin against dysfunctional lipid metabolism, gut dysbiosis, and inflammation.
Norris GH; Milard M; Michalski MC; Blesso CN
J Nutr Biochem; 2019 Nov; 73():108224. PubMed ID: 31654895
[TBL] [Abstract][Full Text] [Related]
2. Milk sphingomyelin improves lipid metabolism and alters gut microbiota in high fat diet-fed mice.
Norris GH; Jiang C; Ryan J; Porter CM; Blesso CN
J Nutr Biochem; 2016 Apr; 30():93-101. PubMed ID: 27012625
[TBL] [Abstract][Full Text] [Related]
3. Milk polar lipids reduce lipid cardiovascular risk factors in overweight postmenopausal women: towards a gut sphingomyelin-cholesterol interplay.
Vors C; Joumard-Cubizolles L; Lecomte M; Combe E; Ouchchane L; Drai J; Raynal K; Joffre F; Meiller L; Le Barz M; Gaborit P; Caille A; Sothier M; Domingues-Faria C; Blot A; Wauquier A; Blond E; Sauvinet V; Gésan-Guiziou G; Bodin JP; Moulin P; Cheillan D; Vidal H; Morio B; Cotte E; Morel-Laporte F; Laville M; Bernalier-Donadille A; Lambert-Porcheron S; Malpuech-Brugère C; Michalski MC
Gut; 2020 Mar; 69(3):487-501. PubMed ID: 31189655
[TBL] [Abstract][Full Text] [Related]
4. Cow's milk polar lipids reduce atherogenic lipoprotein cholesterol, modulate gut microbiota and attenuate atherosclerosis development in LDL-receptor knockout mice fed a Western-type diet.
Millar CL; Jiang C; Norris GH; Garcia C; Seibel S; Anto L; Lee JY; Blesso CN
J Nutr Biochem; 2020 May; 79():108351. PubMed ID: 32007663
[TBL] [Abstract][Full Text] [Related]
5. Dietary sphingolipids: potential for management of dyslipidemia and nonalcoholic fatty liver disease.
Norris GH; Blesso CN
Nutr Rev; 2017 Apr; 75(4):274-285. PubMed ID: 28383715
[TBL] [Abstract][Full Text] [Related]
6. Dietary sphingomyelin attenuates hepatic steatosis and adipose tissue inflammation in high-fat-diet-induced obese mice.
Norris GH; Porter CM; Jiang C; Millar CL; Blesso CN
J Nutr Biochem; 2017 Feb; 40():36-43. PubMed ID: 27855315
[TBL] [Abstract][Full Text] [Related]
7. Milk polar lipids modulate lipid metabolism, gut permeability, and systemic inflammation in high-fat-fed C57BL/6J ob/ob mice, a model of severe obesity.
Zhou AL; Ward RE
J Dairy Sci; 2019 Jun; 102(6):4816-4831. PubMed ID: 30981495
[TBL] [Abstract][Full Text] [Related]
8. Milk Polar Lipids in a High-Fat Diet Can Prevent Body Weight Gain: Modulated Abundance of Gut Bacteria in Relation with Fecal Loss of Specific Fatty Acids.
Milard M; Laugerette F; Durand A; Buisson C; Meugnier E; Loizon E; Louche-Pelissier C; Sauvinet V; Garnier L; Viel S; Bertrand K; Joffre F; Cheillan D; Humbert L; Rainteau D; Plaisancié P; Bindels LB; Neyrinck AM; Delzenne NM; Michalski MC
Mol Nutr Food Res; 2019 Feb; 63(4):e1801078. PubMed ID: 30628158
[TBL] [Abstract][Full Text] [Related]
9. The dietary effect of milk sphingomyelin on the lipid metabolism of obese/diabetic KK-A(y) mice and wild-type C57BL/6J mice.
Yamauchi I; Uemura M; Hosokawa M; Iwashima-Suzuki A; Shiota M; Miyashita K
Food Funct; 2016 Sep; 7(9):3854-67. PubMed ID: 27501823
[TBL] [Abstract][Full Text] [Related]
10. Dietary Sphingomyelin Metabolism and Roles in Gut Health and Cognitive Development.
Jiang C; Cheong LZ; Zhang X; Ali AH; Jin Q; Wei W; Wang X
Adv Nutr; 2022 Mar; 13(2):474-491. PubMed ID: 34549256
[TBL] [Abstract][Full Text] [Related]
11. Dietary sphingomyelin lowers hepatic lipid levels and inhibits intestinal cholesterol absorption in high-fat-fed mice.
Chung RW; Kamili A; Tandy S; Weir JM; Gaire R; Wong G; Meikle PJ; Cohn JS; Rye KA
PLoS One; 2013; 8(2):e55949. PubMed ID: 23409094
[TBL] [Abstract][Full Text] [Related]
12. Grifola frondosa polysaccharides ameliorate lipid metabolic disorders and gut microbiota dysbiosis in high-fat diet fed rats.
Li L; Guo WL; Zhang W; Xu JX; Qian M; Bai WD; Zhang YY; Rao PF; Ni L; Lv XC
Food Funct; 2019 May; 10(5):2560-2572. PubMed ID: 30994668
[TBL] [Abstract][Full Text] [Related]
13. Dietary lipids, gut microbiota and lipid metabolism.
Schoeler M; Caesar R
Rev Endocr Metab Disord; 2019 Dec; 20(4):461-472. PubMed ID: 31707624
[TBL] [Abstract][Full Text] [Related]
14. The Impact of Dietary Sphingolipids on Intestinal Microbiota and Gastrointestinal Immune Homeostasis.
Rohrhofer J; Zwirzitz B; Selberherr E; Untersmayr E
Front Immunol; 2021; 12():635704. PubMed ID: 34054805
[TBL] [Abstract][Full Text] [Related]
15. Insights into a Possible Mechanism Underlying the Connection of Carbendazim-Induced Lipid Metabolism Disorder and Gut Microbiota Dysbiosis in Mice.
Jin C; Zeng Z; Wang C; Luo T; Wang S; Zhou J; Ni Y; Fu Z; Jin Y
Toxicol Sci; 2018 Dec; 166(2):382-393. PubMed ID: 30496565
[TBL] [Abstract][Full Text] [Related]
16. Milk Phospholipids Enhance Lymphatic Absorption of Dietary Sphingomyelin in Lymph-Cannulated Rats.
Morifuji M; Higashi S; Oba C; Ichikawa S; Kawahata K; Yamaji T; Itoh H; Manabe Y; Sugawara T
Lipids; 2015 Oct; 50(10):987-96. PubMed ID: 26233817
[TBL] [Abstract][Full Text] [Related]
17. Crocin-I ameliorates the disruption of lipid metabolism and dysbiosis of the gut microbiota induced by chronic corticosterone in mice.
Xie X; Xiao Q; Xiong Z; Yu C; Zhou J; Fu Z
Food Funct; 2019 Oct; 10(10):6779-6791. PubMed ID: 31576875
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
19. Milk Polar Lipids: Underappreciated Lipids with Emerging Health Benefits.
Anto L; Warykas SW; Torres-Gonzalez M; Blesso CN
Nutrients; 2020 Apr; 12(4):. PubMed ID: 32260440
[TBL] [Abstract][Full Text] [Related]
20. Milk polar lipids favorably alter circulating and intestinal ceramide and sphingomyelin species in postmenopausal women.
Le Barz M; Vors C; Combe E; Joumard-Cubizolles L; Lecomte M; Joffre F; Trauchessec M; Pesenti S; Loizon E; Breyton AE; Meugnier E; Bertrand K; Drai J; Robert C; Durand A; Cuerq C; Gaborit P; Leconte N; Bernalier-Donadille A; Cotte E; Laville M; Lambert-Porcheron S; Ouchchane L; Vidal H; Malpuech-Brugère C; Cheillan D; Michalski MC
JCI Insight; 2021 May; 6(10):. PubMed ID: 33857018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
